Remove 2021 Remove Heart Failure Remove Medicare
article thumbnail

Industry marketing payments to physicians and prescription patterns for sacubitril/valsartan in the USA

Heart BMJ

Methods Using the publicly accessible Centers for Medicare and Medicaid Services Medicare Part D database and the Open Payments Database, this study assessed associations between industry-sponsored meal payments to physician prescribers and total amounts of Medicare claims and spending for sacubitril/valsartan between 2015 and 2021.

article thumbnail

Cardiac resynchronization therapy (CRT) – why is it so important?

Cardiomatics

One of these diseases is heart failure – a condition in which the heart is unable to pump enough blood to the organs in our body. Unfortunately, the number of patients with heart failure continues to grow. Of course, there is drug treatment for heart failure, but it is not always sufficient.

article thumbnail

Published Research

Society of Thoracic Surgeons - Research

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

article thumbnail

Published Research

Society of Thoracic Surgeons - Research

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

article thumbnail

Safety and efficacy of outpatient intravenous diuresis in decompensated heart failure: a systematic review

Frontiers in Cardiovascular Medicine

Demographics, visit data, and outcomes were collected, and 30-day outcomes were compared to inpatient IV (IP IV) diuresis from 2021 Medicare HF hospitalizations.ResultsThe review included 1,590 unique patients treated with OP IV diuretics, with a mean age of 70 ± 6 years, 69.7% male, and 74.8% NYHA III-IV. respectively).